DF Research issued a cautious report on RXO, saying the firm believes lenders forced RXO to replace the unsecured credit with secured because the company is failing. DF believes RXO is left with two choices: “Management can tacitly admit defeat by raising equity capital openly; or they can continue the extend and pretend game by raising more capital than needed while overpaying for an acquisition target.”
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RXO:
- RXO Inc. price target raised to $20 from $18 at Truist
- RXO Inc. price target lowered to $14 from $15 at JPMorgan
- RXO Inc. price target raised to $17 from $16 at BofA
- RXO Inc. price target raised to $17 from $15 at UBS
- Balanced Hold on RXO: Near-Term Earnings Pressure vs. Emerging Truckload Recovery Upside